| ²é¿´: 1710 | »Ø¸´: 40 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û35´Î£¬×÷Õßwanggch123Ôö¼Ó½ð±Ò 31.5 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
wanggch123ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
|
[×ÊÔ´]
¡¾ÆäËû¡¿·ÖÏí ÐÂÒ©ÉóÅú¹ý³ÌNew Drug Approval Process
|
|
|
New Drug Approval Process, Fourth Edition, Accelerating Global Registrations (Drugs and the Pharmaceutical Sciences) Author: Richard Guarino Publisher: Informa HealthCare (May 21, 2004) Media: Hardcover, 664 pages Price: $138.30 ISBN-10: 0824750411 ISBN-13: 9780824750411 Offering expert guidance on the clinical, regulatory, and statistical processes involved in the development of new pharmaceutical product applications for drugs, biologicals, and medical devices, the fourth edition details the specific regulations, guidelines, and procedures that will advance and ensure approval of United States and global new product applications. It communicates and integrates a new approach to the world of pharmaceutical personnel on all aspects of new product development and alerts readers to clinical and regulatory tasks that require immediate attention and long-term follow-up in order to comply with the international acceptance of new product approvals. ÏÂÔØµØÖ· http://g.zhubajie.com/urllink.php?id=6086172spo08ikmkg19gfj6 ¶à¶àÆÀ¼ÛŶ£¡ |
» ²ÂÄãϲ»¶
ÎÄÏ×·ÖÏí | Nature×ÛÊö£ºÖÐɽ´óѧÍŶӲûÊö°ÐÏòÖ×Áö»îÐÔÑõ£¨ROS£©µÄÔÀíÓë²ßÂÔ
ÒѾÓÐ5È˻ظ´
Óг¥Ç󳦶¾ËصĴàÈõÄâ¸Ë¾ú£¨ETBF£©
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ173È˻ظ´
Éú·À¾úµÄÅèÔÔ·ÀЧʵÑé
ÒѾÓÐ1È˻ظ´
Çë½Ì´óÀÐÀ©É¢ÎÊÌâ
ÒѾÓÐ5È˻ظ´
ÖÐÎÄͶ¸å¡°Ö×ÁöÃâÒß¡±Ïà¹Ø
ÒѾÓÐ6È˻ظ´
2025ÄêҩѧרҵÇóµ÷¼Á
ÒѾÓÐ1È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
41Â¥2009-11-06 22:22:23
5Â¥2009-09-24 12:42:53
9Â¥2009-09-24 16:15:29
¼òµ¥»Ø¸´
chemosky13Â¥
2009-09-24 20:36
»Ø¸´


















»Ø¸´´ËÂ¥
5